OM:BINVBiotechs
Moderna Cancer Vaccine Buzz Is Shining A Light On Smaller Immuno Oncology Stocks
The mRNA cancer vaccine breakthrough from Moderna and Merck has pushed this once speculative corner of biotech into the spotlight, and investors are taking notice of how quickly expectations can reset when trial data shifts the story. That kind of sharp repricing can create both opportunity and risk if you are exposed to similar news. This article walks through 3 stocks linked to this catalyst so you can judge whether they still fit your portfolio.
The three stocks below are a useful sample...